Back
Halozyme Therapeutics Stock Price Chart
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
57
HALO
Halozyme Therapeutics
Last Price:
$53.43
Seasonality Move:
2.19%
7 Day Trial
ALL ACCESS PASS
$
7
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight buying pressure.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.69 | Buy |
| 20-day SMA: | 56.68 | Sell |
| 50-day SMA: | 59.27 | Sell |
| 200-day SMA: | 56.35 | Sell |
| 8-day EMA: | 55 | Buy |
| 20-day EMA: | 56.03 | Sell |
| 50-day EMA: | 57.7 | Sell |
| 200-day EMA: | 55.31 | Buy |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.39 | Sell |
| Relative Strength Index (14 RSI): | 47.36 | Sell |
| Chaikin Money Flow: | 502401 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.73 - 63.29) | Sell |
| Bollinger Bands (100): | (54.11 - 62.51) | Sell |
Halozyme Therapeutics Technical Analysis
| May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 55.64 while HALO 8-day simple moving average is 54.69, which is a Buy signal.
-
The stock price of HALO is 55.64 while Halozyme Therapeutics 20-day SMA is 56.68, which makes it a Sell.
-
Halozyme Therapeutics 50-day simple moving average is 59.27 while HALO share price is 55.64, making it a Sell technically.
-
HALO stock price is 55.64 and Halozyme Therapeutics 200-day simple moving average is 56.35, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
57
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a BuyThe current Halozyme Therapeutics [HALO] share price is $55.64. The Score for HALO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
6.9B
Price in USD:
55.64
Share Volume:
1.9M
Halozyme Therapeutics 52-Week Range
52-Week High:
70.51
52-Week Low:
42.01
Buy
57
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?The Halozyme Therapeutics stock price is 55.64 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 55.64 while HALO 8-day exponential moving average is 55.00, which is a Buy signal.
-
The stock price of HALO is 55.64 while Halozyme Therapeutics 20-day EMA is 56.03, which makes it a Sell.
-
Halozyme Therapeutics 50-day exponential moving average is 57.70 while HALO share price is 55.64, making it a Sell technically.
-
HALO stock price is 55.64 and Halozyme Therapeutics 200-day simple moving average is 55.31, creating a Buy signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -1.39, suggesting Halozyme Therapeutics is a Sell
-
Halozyme Therapeutics Relative Strength Index (RSI) is 47.36, which suggest Halozyme Therapeutics is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics is (51.73 - 63.29), which suggest Halozyme Therapeutics is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics is (54.11 - 62.51), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.